Stay updated on ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Site revision tag updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-13T17:56:22.000Z thumbnail image
  3. Check
    30 days ago
    Change Detected
    Summary
    Introduced a dedicated Locations section listing California, Missouri, and New York, replacing the previous per-state location entries; the page version updated to v3.3.3.
    Difference
    0.4%
    Check dated 2025-12-23T09:21:32.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Mia Weiss, M.D. was added as an investigator and Brian A. Van Tine, M.D., Ph.D. was removed from the study record.
    Difference
    0.4%
    Check dated 2025-12-16T03:06:36.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page shows a new Revision: v3.3.2 and previously displayed Revision: v3.2.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T20:55:47.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice about NIH Clinical Center's operating status; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T18:12:58.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The new screenshot shows only minor formatting and wording adjustments on the Study Details page; there are no changes to the core content such as study title, status, eligibility, interventions, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T12:53:31.000Z thumbnail image

Stay in the know with updates to ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ADI-PEG 20 with Gemcitabine/Docetaxel in Sarcomas/Lung Cancer Clinical Trial page.